{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:23:02Z","timestamp":1790022182105,"version":"4.0.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12016-021-08844-7","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T03:02:27Z","timestamp":1611630147000},"page":"90-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Eosinophils in the Field of Nasal Polyposis: Towards a Better Understanding of Biologic Therapies"],"prefix":"10.1007","volume":"62","author":[{"given":"Thibault","family":"Vanderhaegen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dendooven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Chenivesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1592-1625","authenticated-orcid":false,"given":"Geoffrey","family":"Mortuaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"8844_CR1","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al (2020) European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology 58(Suppl S29):1\u2011464","DOI":"10.4193\/Rhin20.601"},{"issue":"9","key":"8844_CR2","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/lary.27852","volume":"129","author":"N Bhattacharyya","year":"2019","unstructured":"Bhattacharyya N, Villeneuve S, Joish VN, Amand C, Mannent L, Amin N et al (2019) Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope 129(9):1969\u20131975","journal-title":"Laryngoscope"},{"issue":"2","key":"8844_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1398-9995.2005.00688.x","volume":"60","author":"JM Klossek","year":"2005","unstructured":"Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I et al (2005) Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy 60(2):233\u2013237","journal-title":"Allergy"},{"issue":"3","key":"8844_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","volume":"135","author":"JP Rajan","year":"2015","unstructured":"Rajan JP, Wineinger NE, Stevenson DD, White AA (2015) Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol 135(3):676-681.e1","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8844_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/cea.12472","volume":"45","author":"KE Hulse","year":"2015","unstructured":"Hulse KE, Stevens WW, Tan BK, Schleimer RP (2015) Pathogenesis of nasal polyposis. Clin Exp Allergy J Br Soc Allergy Clin Immunol 45(2):328\u2013346","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"issue":"1","key":"8844_CR6","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1038\/s41598-018-26327-2","volume":"8","author":"T Chalermwatanachai","year":"2018","unstructured":"Chalermwatanachai T, Vilchez-Vargas R, Holtappels G, Lacoere T, J\u00e1uregui R, Kerckhof FM et al (2018) Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota. Sci Rep 8(1):7926","journal-title":"Sci Rep"},{"issue":"1","key":"8844_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.alit.2019.06.007","volume":"69","author":"T Nakayama","year":"2020","unstructured":"Nakayama T, Hirota T, Asaka D, Sakashita M, Ninomiya T, Morikawa T et al (2020) A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations. Allergol Int Off J Jpn Soc Allergol 69(1):138\u2013140","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"issue":"7\u20138","key":"8844_CR8","first-page":"1104","volume":"36","author":"DS Lazard","year":"1983","unstructured":"Lazard DS, Pruli\u00e8re-Escabasse V, Papon JF, Escudier E (1983) Coste A (2007) [Injury and epithelial wound healing: a pathophysiologic hypothesis for nasal and sinus polyposis]. Presse Medicale Paris Fr 36(7\u20138):1104\u20131108","journal-title":"Presse Medicale Paris Fr"},{"issue":"5","key":"8844_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0013.5277","volume":"73","author":"K Radajewski","year":"2019","unstructured":"Radajewski K, Wierzchowska M, Grzanka D, Antosik P, Zdrenka M, Burduk P (2019) Tissue remodelling in chronic rhinosinusitis\u2014review of literature. Otolaryngol Pol Pol Otolaryngol 73(5):1\u20134","journal-title":"Otolaryngol Pol Pol Otolaryngol"},{"issue":"5","key":"8844_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","volume":"137","author":"P Tomassen","year":"2016","unstructured":"Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H et al (2016) Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 137(5):1449-1456.e4","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8844_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jaci.2014.08.031","volume":"135","author":"M Mahdavinia","year":"2015","unstructured":"Mahdavinia M, Suh LA, Carter RG, Stevens WW, Norton JE, Kato A et al (2015) Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia. J Allergy Clin Immunol 135(2):576\u2013579","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8844_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2500\/ajra.2013.27.3922","volume":"27","author":"M Katotomichelakis","year":"2013","unstructured":"Katotomichelakis M, Tantilipikorn P, Holtappels G, De Ruyck N, Feng L, Van Zele T et al (2013) Inflammatory patterns in upper airway disease in the same geographical area may change over time. Am J Rhinol Allergy 27(5):354\u2013360","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"8844_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1248\/bpb.b19-00892","volume":"43","author":"A Kanda","year":"2020","unstructured":"Kanda A, Yasutaka Y, Van Bui D, Suzuki K, Sawada S, Kobayashi Y et al (2020) Multiple biological aspects of eosinophils in host defense, eosinophil-associated diseases, immunoregulation, and homeostasis: is their role beneficial, detrimental, regulator, or bystander? Biol Pharm Bull 43(1):20\u201330","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"8844_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MOH.0000000000000552","volume":"27","author":"EA Mack","year":"2020","unstructured":"Mack EA, Pear WS (2020) Transcription factor and cytokine regulation of eosinophil lineage commitment. Curr Opin Hematol 27(1):27\u201333","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"8844_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1084\/jem.20081756","volume":"206","author":"Y Mori","year":"2009","unstructured":"Mori Y, Iwasaki H, Kohno K, Yoshimoto G, Kikushige Y, Okeda A et al (2009) Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. J Exp Med 206(1):183\u2013193","journal-title":"J Exp Med"},{"issue":"11","key":"8844_CR16","doi-asserted-by":"publisher","first-page":"F43","DOI":"10.1084\/jem.20020636","volume":"195","author":"K McNagny","year":"2002","unstructured":"McNagny K, Graf T (2002) Making eosinophils through subtle shifts in transcription factor expression. J Exp Med 195(11):F43-47","journal-title":"J Exp Med"},{"key":"8844_CR17","doi-asserted-by":"crossref","unstructured":"Du J, Stankiewicz MJ, Liu Y, Xi Q, Schmitz JE, Lekstrom-Himes JA, et al (2002) Novel combinatorial interactions of GATA-1, PU.1, and C\/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem 277(45):43481\u201194","DOI":"10.1074\/jbc.M204777200"},{"key":"8844_CR18","doi-asserted-by":"crossref","unstructured":"Gombart AF, Kwok SH, Anderson KL, Yamaguchi Y, Torbett BE, Koeffler HP (2003) Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C\/EBP epsilon and PU.1. Blood 101(8):3265\u201173","DOI":"10.1182\/blood-2002-04-1039"},{"key":"8844_CR19","first-page":"7","volume":"6","author":"N Zimmermann","year":"2005","unstructured":"Zimmermann N, Colyer JL, Koch LE, Rothenberg ME (2005) Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1. BMC 6:7","journal-title":"BMC"},{"key":"8844_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0065-2776(08)01006-7","volume":"101","author":"K Takatsu","year":"2009","unstructured":"Takatsu K, Kouro T, Nagai Y (2009) Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 101:191\u2013236","journal-title":"Adv Immunol"},{"issue":"1","key":"8844_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaci.2011.03.017","volume":"128","author":"JA Poposki","year":"2011","unstructured":"Poposki JA, Uzzaman A, Nagarkar DR, Chustz RT, Peters AT, Suh LA et al (2011) Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 128(1):73-81.e4","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8844_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1189\/jlb.0108058","volume":"85","author":"LA Spencer","year":"2009","unstructured":"Spencer LA, Szela CT, Perez SAC, Kirchhoffer CL, Neves JS, Radke AL et al (2009) Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 85(1):117\u2013123","journal-title":"J Leukoc Biol"},{"issue":"1","key":"8844_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.183.1.195","volume":"183","author":"PS Foster","year":"1996","unstructured":"Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183(1):195\u2013201","journal-title":"J Exp Med"},{"issue":"8","key":"8844_CR24","first-page":"4043","volume":"193","author":"PC Fulkerson","year":"1950","unstructured":"Fulkerson PC, Schollaert KL, Bouffi C (1950) Rothenberg ME (2014) IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation. J Immunol Baltim Md 193(8):4043\u20134052","journal-title":"J Immunol Baltim Md"},{"issue":"4","key":"8844_CR25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","volume":"50","author":"M Dougan","year":"2019","unstructured":"Dougan M, Dranoff G, Dougan SK (2019) GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity 50(4):796\u2013811","journal-title":"Immunity"},{"issue":"9","key":"8844_CR26","first-page":"3445","volume":"197","author":"LK Johnston","year":"1950","unstructured":"Johnston LK, Hsu CL, Krier-Burris RA, Chhiba KD, Chien KB, McKenzie A et al (1950) (2016) IL-33 Precedes IL-5 in regulating eosinophil commitment and is required for eosinophil homeostasis. J Immunol Baltim Md 197(9):3445\u20133453","journal-title":"J Immunol Baltim Md"},{"issue":"3","key":"8844_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1165\/ajrcmb.20.3.3060","volume":"20","author":"YK Kim","year":"1999","unstructured":"Kim YK, Uno M, Hamilos DL, Beck L, Bochner B, Schleimer R et al (1999) Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids. Am J Respir Cell Mol Biol 20(3):388\u2013397","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"8844_CR28","first-page":"1538","volume":"164","author":"L Cameron","year":"1950","unstructured":"Cameron L, Christodoulopoulos P, Lavigne F, Nakamura Y, Eidelman D, McEuen A et al (1950) (2000) Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol Baltim Md 164(3):1538\u20131545","journal-title":"J Immunol Baltim Md"},{"issue":"4","key":"8844_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.anai.2015.01.012","volume":"114","author":"G Mortuaire","year":"2015","unstructured":"Mortuaire G, Gengler I, Vandenhende-Szymanski C, Delbeke M, Gatault S, Chevalier D et al (2015) Immune profile modulation of blood and mucosal eosinophils in nasal polyposis with concomitant asthma. Ann Allergy Asthma Immunol 114(4):299-307.e2","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"8844_CR30","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.waojou.2019.100052","volume":"12","author":"K Wang","year":"2019","unstructured":"Wang K, Deng J, Yang M, Chen Y, Chen F, Gao WX et al (2019) Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps. World Allergy Organ J 12(8):100052","journal-title":"World Allergy Organ J"},{"issue":"5","key":"8844_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/alr.22079","volume":"8","author":"V Dupuch","year":"2018","unstructured":"Dupuch V, Tridon A, Ughetto S, Walrand S, Bonnet B, Dubray C et al (2018) Activation state of circulating eosinophils in nasal polyposis. Int Forum Allergy Rhinol 8(5):584\u2013591","journal-title":"Int Forum Allergy Rhinol"},{"issue":"19","key":"8844_CR32","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1182\/blood-2012-07-443424","volume":"120","author":"N Farahi","year":"2012","unstructured":"Farahi N, Singh NR, Heard S, Loutsios C, Summers C, Solanki CK et al (2012) Use of 111-Indium- labeled autologous eosinophils to establish the in vivo kinetics of human eosinophils in healthy subjects. Blood 120(19):4068\u20134071","journal-title":"Blood"},{"issue":"12","key":"8844_CR33","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/alr.22194","volume":"8","author":"T McHugh","year":"2018","unstructured":"McHugh T, Snidvongs K, Xie M, Banglawala S, Sommer D (2018) High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol 8(12):1421\u20131429","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"8844_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/alr.22517","volume":"10","author":"D Sharbel","year":"2020","unstructured":"Sharbel D, Li M, Unsal AA, Tadros SY, Lee J, Biddinger P et al (2020) Use of mucosal eosinophil count as a guide in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol 10(4):474\u2013480","journal-title":"Int Forum Allergy Rhinol"},{"issue":"12","key":"8844_CR35","first-page":"1447","volume":"30","author":"G Mortuaire","year":"2015","unstructured":"Mortuaire G, Leroy X, Gengler I, Chevalier D, Prin L, Picry A (2015) Histopathological classification of refractory chronic rhinosinusitis with nasal polyps. Histol Histopathol 30(12):1447\u20131454","journal-title":"Histol Histopathol"},{"issue":"1","key":"8844_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/alr.22206","volume":"9","author":"NN Patel","year":"2019","unstructured":"Patel NN, Kohanski MA, Maina IW, Workman AD, Herbert DR, Cohen NA (2019) Sentinels at the wall: epithelial-derived cytokines serve as triggers of upper airway type 2 inflammation. Int Forum Allergy Rhinol 9(1):93\u201399","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"8844_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/alr.21237","volume":"4","author":"G Paris","year":"2014","unstructured":"Paris G, Pozharskaya T, Asempa T, Lane AP (2014) Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells. Int Forum Allergy Rhinol 4(1):15\u201321","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"8844_CR38","first-page":"235","volume":"45","author":"K Yoshifuku","year":"2007","unstructured":"Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y (2007) IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 45(3):235\u2013241","journal-title":"Rhinology"},{"issue":"3","key":"8844_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.alit.2016.01.001","volume":"65","author":"H Saito","year":"2016","unstructured":"Saito H, Honda K, Asaka C, Ueki S, Ishikawa K (2016) Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: role of CC-chemokine receptor 3. Allergol Int Off J Jpn Soc Allergol 65(3):280\u2013285","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"issue":"1","key":"8844_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/194589240501900103","volume":"19","author":"JE Meyer","year":"2005","unstructured":"Meyer JE, Bartels J, G\u00f6r\u00f6gh T, Sticherling M, Rudack C, Ross DA et al (2005) The role of RANTES in nasal polyposis. Am J Rhinol 19(1):15\u201320","journal-title":"Am J Rhinol"},{"key":"8844_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fmed.2017.00104","volume":"4","author":"M Peinhaupt","year":"2017","unstructured":"Peinhaupt M, Sturm EM, Heinemann A (2017) Prostaglandins and their receptors in eosinophil function and as therapeutic targets. Front Med 4:104","journal-title":"Front Med"},{"issue":"12","key":"8844_CR42","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1111\/all.13974","volume":"74","author":"I Tojima","year":"2019","unstructured":"Tojima I, Matsumoto K, Kikuoka H, Hara S, Yamamoto S, Shimizu S et al (2019) Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D2 and cysteinyl leukotrienes in allergic rhinitis. Allergy 74(12):2417\u20132426","journal-title":"Allergy"},{"issue":"12","key":"8844_CR43","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/intimm\/8.12.1915","volume":"8","author":"K Kotowicz","year":"1996","unstructured":"Kotowicz K, Callard RE, Friedrich K, Matthews DJ, Klein N (1996) Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int Immunol 8(12):1915\u20131925","journal-title":"Int Immunol"},{"issue":"1","key":"8844_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","volume":"13","author":"HF Rosenberg","year":"2013","unstructured":"Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13(1):9\u201322","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"8844_CR45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1165\/ajrcmb.12.6.7539273","volume":"12","author":"FL Jahnsen","year":"1995","unstructured":"Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P (1995) Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 12(6):624\u2013632","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"8844_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1165\/ajrcmb.15.4.8879177","volume":"15","author":"DL Hamilos","year":"1996","unstructured":"Hamilos DL, Leung DY, Wood R, Bean DK, Song YL, Schotman E et al (1996) Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS\/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 15(4):443\u2013450","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"8844_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1084\/jem.180.1.371","volume":"180","author":"FA Symon","year":"1994","unstructured":"Symon FA, Walsh GM, Watson SR, Wardlaw AJ (1994) Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 180(1):371\u2013376","journal-title":"J Exp Med"},{"issue":"10","key":"8844_CR48","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1182\/blood.V92.10.3904","volume":"92","author":"KD Patel","year":"1998","unstructured":"Patel KD (1998) Eosinophil tethering to interleukin-4-activated endothelial cells requires both P-selectin and vascular cell adhesion molecule-1. Blood 92(10):3904\u20133911","journal-title":"Blood"},{"issue":"3","key":"8844_CR49","first-page":"377","volume":"266","author":"A Eweiss","year":"2009","unstructured":"Eweiss A, Dogheim Y, Hassab M, Tayel H, Hammad Z (2009) VCAM-1 and eosinophilia in diffuse sino-nasal polyps. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg 266(3):377\u2013383","journal-title":"Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg"},{"key":"8844_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","volume":"5","author":"F Davoine","year":"2014","unstructured":"Davoine F, Lacy P (2014) Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol 5:570","journal-title":"Front Immunol"},{"key":"8844_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fmed.2017.00093","volume":"4","author":"CN McBrien","year":"2017","unstructured":"McBrien CN, Menzies-Gow A (2017) The biology of eosinophils and their role in asthma. Front Med (Lausanne) 4:93","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"8844_CR52","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/nri.2017.95","volume":"17","author":"PF Weller","year":"2017","unstructured":"Weller PF, Spencer LA (2017) Functions of tissue-resident eosinophils. Nat Rev Immunol 17(12):746\u2013760","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"8844_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3346\/jkms.2002.17.3.375","volume":"17","author":"K-S Suh","year":"2002","unstructured":"Suh K-S, Park HS, Nahm DH, Kim YK, Lee YM, Park K (2002) Role of IgG, IgA, and IgE antibodies in nasal polyp tissue: their relationships with eosinophilic infiltration and degranulation. J Korean Med Sci 17(3):375\u2013380","journal-title":"J Korean Med Sci"},{"issue":"Suppl 1","key":"8844_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000077791","volume":"134","author":"M Kato","year":"2004","unstructured":"Kato M, Kita H, Tachibana A, Hayashi Y, Tsuchida Y, Kimura H (2004) Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. Int Arch Allergy Immunol 134(Suppl 1):37\u201343","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"8844_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2567.2012.03556.x","volume":"136","author":"AM Kvarnhammar","year":"2012","unstructured":"Kvarnhammar AM, Cardell LO (2012) Pattern-recognition receptors in human eosinophils. Immunology 136(1):11\u201320","journal-title":"Immunology"},{"issue":"1","key":"8844_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/JLB.3MR1217-476R","volume":"104","author":"RCN Melo","year":"2018","unstructured":"Melo RCN, Weller PF (2018) Contemporary understanding of the secretory granules in human eosinophils. J Leukoc Biol 104(1):85\u201393","journal-title":"J Leukoc Biol"},{"issue":"9","key":"8844_CR57","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nm.1855","volume":"14","author":"S Yousefi","year":"2008","unstructured":"Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E et al (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14(9):949\u2013953","journal-title":"Nat Med"},{"issue":"11","key":"8844_CR58","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","volume":"121","author":"S Ueki","year":"2013","unstructured":"Ueki S, Melo RCN, Ghiran I, Spencer LA, Dvorak AM, Weller PF (2013) Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood 121(11):2074\u20132083","journal-title":"Blood"},{"issue":"8","key":"8844_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11882-016-0634-5","volume":"16","author":"S Ueki","year":"2016","unstructured":"Ueki S, Tokunaga T, Fujieda S, Honda K, Hirokawa M, Spencer LA et al (2016) Eosinophil ETosis and DNA traps: a new look at eosinophilic inflammation. Curr Allergy Asthma Rep 16(8):54","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"8844_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1189\/jlb.3A1015-480R","volume":"100","author":"LAS Carmo","year":"2016","unstructured":"Carmo LAS, Bonjour K, Ueki S, Neves JS, Liu L, Spencer LA et al (2016) CD63 is tightly associated with intracellular, secretory events chaperoning piecemeal degranulation and compound exocytosis in human eosinophils. J Leukoc Biol 100(2):391\u2013401","journal-title":"J Leukoc Biol"},{"issue":"5","key":"8844_CR61","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2500\/ajra.2009.23.3357","volume":"23","author":"M Armengot","year":"2009","unstructured":"Armengot M, Gar\u00edn L, Carda C (2009) Eosinophil degranulation patterns in nasal polyposis: an ultrastructural study. Am J Rhinol Allergy 23(5):466\u2013470","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"8844_CR62","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1067\/mai.2000.108311","volume":"106","author":"T Fujisawa","year":"2000","unstructured":"Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K et al (2000) Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 106(3):507\u2013513","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"8844_CR63","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/153537020222700814","volume":"227","author":"AP Badewa","year":"2002","unstructured":"Badewa AP, Hudson CE, Heiman AS (2002) Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Exp Biol Med Maywood NJ 227(8):645\u2013651","journal-title":"Exp Biol Med Maywood NJ"},{"issue":"8","key":"8844_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1398-9995.1996.tb04669.x","volume":"51","author":"S Takafuji","year":"1996","unstructured":"Takafuji S, Tadokoro K, Ito K (1996) Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. Allergy 51(8):563\u2013568","journal-title":"Allergy"},{"issue":"2","key":"8844_CR65","first-page":"438","volume":"204","author":"ME Coden","year":"1950","unstructured":"Coden ME, Loffredo LF, Walker MT, Jeong BM, Nam K, Bochner BS et al (1950) (2020) Fibrinogen is a specific trigger for cytolytic eosinophil degranulation. J Immunol Baltim Md 204(2):438\u2013448","journal-title":"J Immunol Baltim Md"},{"issue":"7","key":"8844_CR66","first-page":"981","volume":"266","author":"DI Sun","year":"2009","unstructured":"Sun DI, Joo YH, Auo HJ, Kang JM (2009) Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg 266(7):981\u2013986","journal-title":"Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg"},{"issue":"1","key":"8844_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/intimm\/dxy061","volume":"31","author":"T Tsuda","year":"2019","unstructured":"Tsuda T, Maeda Y, Nishide M, Koyama S, Hayama Y, Nojima S et al (2019) Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity. Int Immunol 31(1):33\u201340","journal-title":"Int Immunol"},{"issue":"7","key":"8844_CR68","first-page":"4861","volume":"177","author":"S P\u00e9gorier","year":"1950","unstructured":"P\u00e9gorier S, Wagner LA, Gleich GJ (1950) Pretolani M (2006) Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol Baltim Md 177(7):4861\u20134869","journal-title":"J Immunol Baltim Md"},{"issue":"9","key":"8844_CR69","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1182\/blood-2003-01-0151","volume":"102","author":"D Yang","year":"2003","unstructured":"Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K, Oppenheim JJ (2003) Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102(9):3396\u20133403","journal-title":"Blood"},{"issue":"9","key":"8844_CR70","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1398-9995.2012.02868.x","volume":"67","author":"M Morshed","year":"2012","unstructured":"Morshed M, Yousefi S, St\u00f6ckle C, Simon HU, Simon D (2012) Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy 67(9):1127\u20131137","journal-title":"Allergy"},{"issue":"6","key":"8844_CR71","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.coi.2012.08.010","volume":"24","author":"S Yousefi","year":"2012","unstructured":"Yousefi S, Simon D, Simon HU (2012) Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr Opin Immunol 24(6):736\u2013739","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"8844_CR72","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","volume":"139","author":"E Gevaert","year":"2017","unstructured":"Gevaert E, Zhang N, Krysko O, Lan F, Holtappels G, De Ruyck N et al (2017) Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J Allergy Clin Immunol 139(6):1849-1860.e6","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8844_CR73","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1177\/0194599819838782","volume":"160","author":"AE Lehmann","year":"2019","unstructured":"Lehmann AE, Scangas GA, Bergmark RW, El Rassi E, Stankovic KM, Metson R (2019) Periostin and inflammatory disease: implications for chronic rhinosinusitis. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 160(6):965\u2013973","journal-title":"Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg"},{"issue":"1","key":"8844_CR74","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1038\/s41598-019-44627-z","volume":"9","author":"CS Hwang","year":"2019","unstructured":"Hwang CS, Park SC, Cho HJ, Park DJ, Yoon JH, Kim CH (2019) Eosinophil extracellular trap formation is closely associated with disease severity in chronic rhinosinusitis regardless of nasal polyp status. Sci Rep 9(1):8061","journal-title":"Sci Rep"},{"issue":"3","key":"8844_CR75","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20071840","volume":"205","author":"EA Jacobsen","year":"2008","unstructured":"Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, Colbert DC et al (2008) Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 205(3):699\u2013710","journal-title":"J Exp Med"},{"issue":"8","key":"8844_CR76","first-page":"2626","volume":"145","author":"JN Moy","year":"1950","unstructured":"Moy JN, Gleich GJ (1950) Thomas LL (1990) Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol Baltim Md 145(8):2626\u20132632","journal-title":"J Immunol Baltim Md"},{"issue":"1","key":"8844_CR77","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.it.2018.11.001","volume":"40","author":"MJ Schuijs","year":"2019","unstructured":"Schuijs MJ, Hammad H, Lambrecht BN (2019) Professional and \u2018amateur\u2019 antigen- presenting cells in type 2 immunity. Trends Immunol 40(1):22\u201334","journal-title":"Trends Immunol"},{"issue":"1","key":"8844_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cei.12695","volume":"183","author":"C Berek","year":"2016","unstructured":"Berek C (2016) Eosinophils: important players in humoral immunity. Clin Exp Immunol 183(1):57\u201364","journal-title":"Clin Exp Immunol"},{"key":"8844_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fmed.2017.00101","volume":"4","author":"T Marichal","year":"2017","unstructured":"Marichal T, Mesnil C, Bureau F (2017) Homeostatic eosinophils: characteristics and functions. Front Med 4:101","journal-title":"Front Med"},{"issue":"1","key":"8844_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/JLB.1MR1117-442RR","volume":"104","author":"H Abdala-Valencia","year":"2018","unstructured":"Abdala-Valencia H, Coden ME, Chiarella SE, Jacobsen EA, Bochner BS, Lee JJ et al (2018) Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. J Leukoc Biol 104(1):95\u2013108","journal-title":"J Leukoc Biol"},{"issue":"4","key":"8844_CR81","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2222.2010.03484.x","volume":"40","author":"JJ Lee","year":"2010","unstructured":"Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA (2010) Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy J Br Soc Allergy Clin Immunol 40(4):563\u2013575","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"issue":"9","key":"8844_CR82","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1172\/JCI85664","volume":"126","author":"C Mesnil","year":"2016","unstructured":"Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D et al (2016) Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest 126(9):3279\u20133295","journal-title":"J Clin Invest"},{"issue":"2","key":"8844_CR83","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/imm.12885","volume":"154","author":"JJ Xenakis","year":"2018","unstructured":"Xenakis JJ, Howard ED, Smith KM, Olbrich CL, Huang Y, Anketell D et al (2018) Resident intestinal eosinophils constitutively express antigen presentation markers and include two phenotypically distinct subsets of eosinophils. Immunology 154(2):298\u2013308","journal-title":"Immunology"},{"issue":"2","key":"8844_CR84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jaip.2015.01.013","volume":"3","author":"F Legrand","year":"2015","unstructured":"Legrand F, Klion AD (2015) Biologic therapies targeting eosinophils: current status and future prospects. J Allergy Clin Immunol Pract 3(2):167\u2013174","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"8844_CR85","first-page":"444","volume":"58","author":"G Mortuaire","year":"2020","unstructured":"Mortuaire G, Gengler I, Carpentier C, Szymanski C, Chenivesse C, Lefevre G (2020) T helper 2 inflammatory markers are associated with recurrence in chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery. Rhinology 58(5):444\u2013450","journal-title":"Rhinology"},{"issue":"4","key":"8844_CR86","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1067\/mai.2001.112374","volume":"107","author":"C Bachert","year":"2001","unstructured":"Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P (2001) Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107(4):607\u2013614","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8844_CR87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00621.x","volume":"60","author":"P Gevaert","year":"2005","unstructured":"Gevaert P, Holtappels G, Johansson SGO, Cuvelier C, Cauwenberge P, Bachert C (2005) Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 60(1):71\u201379","journal-title":"Allergy"},{"issue":"3","key":"8844_CR88","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4193\/Rhino09.144","volume":"48","author":"JM Pinto","year":"2010","unstructured":"Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM (2010) A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology 48(3):318\u2013324","journal-title":"Rhinology"},{"issue":"1","key":"8844_CR89","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","volume":"131","author":"P Gevaert","year":"2013","unstructured":"Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W et al (2013) Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131(1):110-116.e1","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8844_CR90","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE et al (2020) Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol 146(3):595\u2013605","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8844_CR91","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","volume":"118","author":"P Gevaert","year":"2006","unstructured":"Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T et al (2006) Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118(5):1133\u20131141","journal-title":"J Allergy Clin Immunol"},{"key":"8844_CR92","doi-asserted-by":"crossref","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al (2011) Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128(5):989\u2013995.e1\u20138","DOI":"10.1016\/j.jaci.2011.07.056"},{"issue":"4","key":"8844_CR93","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","volume":"140","author":"C Bachert","year":"2017","unstructured":"Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S et al (2017) Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol 140(4):1024-1031.e14","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8844_CR94","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P et al (2016) Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA 315(5):469\u2013479","journal-title":"JAMA"},{"issue":"10209","key":"8844_CR95","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet Lond Engl 394(10209):1638\u20131650","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"8844_CR96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4193\/Rhin17.156","volume":"56","author":"N Tsetsos","year":"2018","unstructured":"Tsetsos N, Goudakos JK, Daskalakis D, Konstantinidis I, Markou K (2018) Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review. Rhinology 56(1):11\u201321","journal-title":"Rhinology"},{"key":"8844_CR97","doi-asserted-by":"crossref","unstructured":"Chong LY, Piromchai P, Sharp S, Snidvongs K, Philpott C, Hopkins C, et al (2020) Biologics for chronic rhinosinusitis. Cochrane Database Syst Rev 2:CD013513","DOI":"10.1002\/14651858.CD013513.pub2"},{"issue":"5","key":"8844_CR98","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1398-9995.2008.01885.x","volume":"64","author":"P Gevaert","year":"2009","unstructured":"Gevaert P, Hellman C, Lundblad L, Lundahl J, Holtappels G, van Cauwenberge P et al (2009) Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients. Allergy 64(5):725\u2013732","journal-title":"Allergy"},{"issue":"9","key":"8844_CR99","first-page":"4427","volume":"160","author":"P Wang","year":"1950","unstructured":"Wang P, Wu P, Cheewatrakoolpong B, Myers JG, Egan RW (1950) Billah MM (1998) Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. J Immunol Baltim Md 160(9):4427\u20134432","journal-title":"J Immunol Baltim Md"},{"issue":"11","key":"8844_CR100","first-page":"5359","volume":"170","author":"B Gregory","year":"1950","unstructured":"Gregory B, Kirchem A, Phipps S, Gevaert P, Pridgeon C, Rankin SM et al (1950) (2003) Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. J Immunol Baltim Md 170(11):5359\u20135366","journal-title":"J Immunol Baltim Md"},{"issue":"11","key":"8844_CR101","first-page":"6459","volume":"169","author":"LY Liu","year":"1950","unstructured":"Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H et al (1950) (2002) Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol Baltim Md 169(11):6459\u20136466","journal-title":"J Immunol Baltim Md"},{"issue":"4","key":"8844_CR102","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/cea.12244","volume":"44","author":"H Neighbour","year":"2014","unstructured":"Neighbour H, Boulet LP, Lemiere C, Sehmi R, Leigh R, Sousa AR et al (2014) Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial. Clin Exp Allergy J Br Soc Allergy Clin Immunol 44(4):508\u2013516","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"issue":"2","key":"8844_CR103","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaci.2018.05.003","volume":"143","author":"M Grozdanovic","year":"2019","unstructured":"Grozdanovic M, Laffey KG, Abdelkarim H, Hitchinson B, Harijith A, Moon HG et al (2019) Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness. J Allergy Clin Immunol 143(2):669-680.e12","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8844_CR104","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000501637","volume":"180","author":"BA Youngblood","year":"2019","unstructured":"Youngblood BA, Brock EC, Leung J, Falahati R, Bryce PJ, Bright J et al (2019) AK002, a humanized sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice. Int Arch Allergy Immunol 180(2):91\u2013102","journal-title":"Int Arch Allergy Immunol"},{"issue":"17","key":"8844_CR105","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","volume":"383","author":"ES Dellon","year":"2020","unstructured":"Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M et al (2020) Anti-Siglec-8 Antibody for eosinophilic gastritis and duodenitis. N Engl J Med 383(17):1624\u20131634","journal-title":"N Engl J Med"},{"issue":"1","key":"8844_CR106","doi-asserted-by":"publisher","first-page":"e007709","DOI":"10.1136\/bmjopen-2015-007709","volume":"6","author":"NA Molfino","year":"2016","unstructured":"Molfino NA, Kuna P, Leff JA, Oh CK, Singh D, Chernow M et al (2016) Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma. BMJ Open 6(1):e007709","journal-title":"BMJ Open"},{"issue":"10","key":"8844_CR107","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJMoa1704064","volume":"377","author":"J Corren","year":"2017","unstructured":"Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM et al (2017) Tezepelumab in adults with uncontrolled asthma. N Engl J Med 377(10):936\u2013946","journal-title":"N Engl J Med"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08844-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08844-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08844-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T12:26:35Z","timestamp":1674908795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08844-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["8844"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08844-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"19 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GM reports grants from AstraZeneca, speaker and consultant honoraria from Sanofi Regeneron and Novartis, outside the submitted work. GL report grants from AstraZeneca outside the submitted work. CC report grants from AstraZeneca, speaker and consultant honoraria from Sanofi Regeneron outside the submitted work. The other authors (TV, IG, AD) have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}